SIGHT SCIENCES, INC. Increase (Decrease) in Accounts Payable
SIGHT SCIENCES, INC. (SGHT) reported Increase (Decrease) in Accounts Payable of $555.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $412.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $143.00K, a 86.67% decline year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$398.00K, a 205.57% decline year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$335.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2025 was -$348.00K, a 203.57% decline from fiscal 2024.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2024 was $336.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2023 was -$883.00K.
- SIGHT SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2022 was -$694.00K, a 159.42% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $555.00K 10-Q · filed 2026-08-05 | $157.00K derived: sum of 3 quarters · filed 2026-08-05 | -$178.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $143.00K 10-Q · filed 2026-05-06 | -$255.00K derived: sum of 2 quarters · filed 2026-05-06 | -$590.00K derived: sum of 3 quarters · filed 2026-05-06 | -$1.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$398.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$733.00K derived: sum of 2 quarters · filed 2026-03-04 | -$1.42M derived: sum of 3 quarters · filed 2026-08-05 | -$348.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$335.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.02M derived: sum of 2 quarters · filed 2026-08-05 | $50.00K 10-Q · filed 2025-11-06 | $427.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $385.00K 10-Q · filed 2026-08-05 | $762.00K derived: sum of 3 quarters · filed 2026-08-05 | $94.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.07M 10-Q · filed 2026-05-06 | $1.45M derived: sum of 2 quarters · filed 2026-05-06 | $782.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.04M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$291.00K derived: sum of 2 quarters · filed 2026-03-04 | -$35.00K derived: sum of 3 quarters · filed 2026-03-04 | $336.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | -$668.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$412.00K derived: sum of 2 quarters · filed 2025-11-06 | -$41.00K 10-Q · filed 2025-11-06 | -$1.76M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $627.00K 10-Q · filed 2025-08-07 | -$1.10M derived: sum of 3 quarters · filed 2025-08-07 | -$446.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $371.00K 10-Q · filed 2025-05-08 | -$1.35M derived: sum of 2 quarters · filed 2025-05-08 | -$702.00K derived: sum of 3 quarters · filed 2025-05-08 | -$1.39M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$1.07M derived: sum of 2 quarters · filed 2025-03-07 | -$1.76M derived: sum of 3 quarters · filed 2025-03-07 | -$883.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $651.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$37.00K derived: sum of 2 quarters · filed 2024-11-07 | $841.00K 10-Q · filed 2024-11-07 | $224.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $190.00K 10-Q · filed 2024-08-02 | -$427.00K derived: sum of 3 quarters · filed 2024-08-02 | $104.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $878.00K 10-Q · filed 2024-05-06 | $261.00K derived: sum of 2 quarters · filed 2024-05-06 | $792.00K derived: sum of 3 quarters · filed 2024-05-06 | $432.00K derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | -$617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$86.00K derived: sum of 2 quarters · filed 2024-03-13 | -$446.00K derived: sum of 3 quarters · filed 2024-03-13 | -$694.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $531.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $171.00K derived: sum of 2 quarters · filed 2023-11-07 | -$77.00K 10-Q · filed 2023-11-07 | $1.41M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$608.00K 10-Q · filed 2023-08-07 | $879.00K derived: sum of 3 quarters · filed 2023-08-07 | -$878.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$248.00K 10-Q · filed 2023-05-08 | $1.24M derived: sum of 2 quarters · filed 2023-05-08 | -$518.00K derived: sum of 3 quarters · filed 2023-05-08 | -$151.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$270.00K derived: sum of 2 quarters · filed 2023-03-16 | $97.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.17M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.39M derived: sum of 2 quarters · filed 2022-11-10 | -$319.00K 10-Q · filed 2022-11-10 | $233.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.44M 10-Q · filed 2022-08-11 | $1.99M derived: sum of 3 quarters · filed 2022-08-11 | $1.13M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.07M 10-Q · filed 2022-05-10 | $1.62M derived: sum of 2 quarters · filed 2022-05-10 | $767.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$304.00K derived: sum of 2 quarters · filed 2022-03-24 | $448.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$104.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $752.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |